US-based Whole Foods tube feeding business to be acquired from Swander Pace Capital for an undisclosed fee to strengthen Danone’s medical nutrition portfolio by enabling expansion of enteral tube feeding range Become.
This transaction is part of the Renew Danone strategy. “Restore growth, competitiveness and value creation in the long term”.
Functional Formularies, on the other hand, operates as a provider of organic, whole-food, shelf-stable feeding tube milk, offering an alternative to conventional milk used throughout the medical field.
The company currently serves institutional customers in hospitals and long-term care facilities, as well as online retail customers throughout the United States and Canada.
“Functional Formularies offers a highly differentiated product portfolio.”
Commenting on the move, Jürgen Esser, Danone Deputy Chief Executive Officer and Chief Financial Officer, said: “As a global leader in medical nutrition, we are pleased to welcome Functional Formulary to Danone.
“By adding a highly differentiated product portfolio of functional formularies that complement our existing Real Food Blends brand portfolio, we are further positioned to support the nutritional needs of tube-fed families and patients. I’m sure it will get better.”
In a statement on LinkedIn, Functional Formularies said the company “Nutricia North America Family”Nutricia is a brand owned by Danone and promises: “We will be able to provide better services to people living on tube feeding.”
“We are excited about this new partnership and remain committed to delivering nutrition to as many people as possible.”the statement added.
Headquartered in Paris, France, Danone produces food and beverage products across three categories: essential dairy and plant-based products, water, and specialty nutrition.
With around 90,000 employees and products in more than 120 markets, Danone generated sales of 27.6 billion euros in 2023.
Meanwhile, the company’s brand portfolio includes Actimel, Activia, Alpro, Aptamil, evian, Nutrilon, and Volvic.
In other news, British beer producer Greene King has announced plans to invest £40 million in the development of a “state-of-the-art” brewery in Bury St Edmunds, Suffolk.
